The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life Private Equity Trst

24 Feb 2022 07:00

RNS Number : 6095C
Standard Life Private Eqty Trst PLC
24 February 2022
 

 

London, UK, 24 February 2022

 

Edison issues review on Standard Life Private Equity Trust (SLPE)

Standard Life Private Equity Trust (SLPET) delivered a strong NAV total return (TR) of 37.9% in FY21 to end-September 2021, ahead of the FTSE All-Share index at 27.9%. It benefitted from particularly high deal activity in private markets, benign public equity markets and strong interest in quality private assets in 2021. SLPET continued to pursue its broadened investment mandate, with co-investments making up 11% of NAV at end-FY21 (c 16% accounting for deals post reporting date) and its exposure to secondary investments standing at 12% of NAV at end-FY21. With an overcommitment ratio of 34.5% (at the lower end of its targeted 30-75% range), it is likely to sustain a high level of investment activity into FY22.

 

While competition for quality private assets remains high, we note that SLPET invests primarily in PE mid-market funds, typically of €1.0-5.0bn in size and, increasingly, in lower mid-market players of €150m to €1.0bn in size. In recent years, these funds have overall accumulated less capital that needs to be deployed than PE 'megafunds' of high single-digit billion euros or more in size, which should allow the mid-market funds to be more selective in their investments and time their capital deployment better. At the same time, mid-market funds should have a broader choice of exit routes, as they are less dependent on exits through IPOs and have a wider group of potential corporate and PE buyers (including megafunds).

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPURUPUPPGAW
Date   Source Headline
20th Jul 20154:33 pmRNSTransaction in Own Shares
14th Jul 20157:00 amRNSEstimated NAV at 30 June 2015
9th Jul 201512:59 pmRNSTransaction in Own Shares
9th Jul 201512:51 pmRNSHolding(s) in Company
7th Jul 201510:37 amRNSTransaction in Own Shares
1st Jul 20154:56 pmRNSTransaction in Own Shares
1st Jul 20158:00 amRNSQuarterly Disclosure
1st Jul 20158:00 amRNSTotal Voting Rights
30th Jun 20155:16 pmRNSTransaction in Own Shares
29th Jun 20154:55 pmRNSTransaction in Own Shares
26th Jun 20154:58 pmRNSTransaction in Own Shares
25th Jun 20154:39 pmRNSTransaction in Own Shares
17th Jun 20159:41 amRNSTransaction in Own Shares
12th Jun 20154:37 pmRNSTransaction in Own Shares
12th Jun 20157:00 amRNSEstimated NAV at 31 May 2015
9th Jun 20154:57 pmRNSTransaction in Own Shares
5th Jun 201512:45 pmRNSTransaction in Own Shares
29th May 20157:05 amRNSEstimated NAV at 30 April 2015
29th May 20157:00 amRNSHalf Yearly Report
16th Apr 20157:00 amRNSEstimated NAV at 31 March 2015
1st Apr 201510:00 amRNSQuarterly Disclosure
19th Mar 20157:01 amRNSEstimated NAV at 28 February 2015
19th Mar 20157:00 amRNSQuarterly Trading Statement
2nd Mar 20157:30 amRNSTotal Voting Rights
27th Feb 20155:04 pmRNSHolding(s) in Company
16th Feb 20157:00 amRNSEstimated NAV at 31 January 2015
12th Feb 20159:21 amRNSTransaction in Own Shares
10th Feb 20154:55 pmRNSTransaction in Own Shares
4th Feb 20155:14 pmRNSTransaction in Own Shares
2nd Feb 20159:33 amRNSTotal Voting Rights
30th Jan 20155:04 pmRNSTransaction in Own Shares
28th Jan 20152:32 pmRNSInterim Management Statement
28th Jan 20152:26 pmRNSResult of AGM
9th Jan 201510:31 amRNSHolding(s) in Company
2nd Jan 20159:10 amRNSQuarterly Disclosure
8th Dec 20147:00 amRNSPreliminary Results
3rd Nov 20149:36 amRNSTotal Voting Rights
8th Oct 20144:14 pmRNSTransaction in Own Shares
7th Oct 201411:44 amRNSTransaction in Own Shares
7th Oct 20149:19 amRNSDirector/PDMR Shareholding
1st Oct 20143:35 pmRNSQuarterly Disclosure
1st Oct 20143:33 pmRNSTotal Voting Rights
26th Sep 201411:55 amRNSTransaction in Own Shares
24th Sep 20141:15 pmRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSQuarterly Trading Statement
31st Jul 20142:06 pmRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSInterim Management Statement
1st Jul 20149:00 amRNSQuarterly Disclosure
30th May 20147:00 amRNSHalf Yearly Report
28th May 20143:20 pmRNSDirectorate Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.